SCHEMBL7523971

SCHEMBL7523971

N#Cc1ncccc1Oc1ncc(Cl)cc1[O]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.39
CYP2C9 P11712 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CCR4 P51679 2/20 0.39
CYP19A1 P11511 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PIN1 Q13526 2/20 0.36
PLCG1 P19174 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
APEX1 P27695 1/20 0.35
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.34
PTGER4 P35408 3/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
PTGER2 P43116 1/20 0.34
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911233 0.84 ALOX5AP (0.38) CCR2CYP2C9CYP3A4CYP2C19CCR4
SCHEMBL4910398 0.82 ALDH1A1 (0.49) CCR2CYP2C9CYP3A4CYP2C19CCR4
SCHEMBL4929334 0.74 CCR2 (0.77) CCR2CYP2C9CYP3A4CYP2C19CCR4
SCHEMBL11458038 0.72 CYP19A1 (0.54) CYP2C9CYP2C19CYP19A1SMN1; SMN2ALDH1A1
SCHEMBL11465936 0.71 LMNA (0.43) SMN1; SMN2ALDH1A1LMNATSHRKMT2A
SCHEMBL3179011 0.68 PLCG1 (0.47) SMN1; SMN2ALDH1A1PLCG1LMNAKMT2A
SCHEMBL5072430 0.67 PLCG1 (0.48) ALDH1A1PLCG1ALOX5APFEN1SLC22A12
SCHEMBL6054468 0.67 ALDH1A1 (0.44) CYP2C9CYP2C19CYP19A1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL30209361 0.67 PLCG1 (0.46) SMN1; SMN2ALDH1A1PLCG1LMNAKMT2A
SCHEMBL11476143 0.67 RAB9A (0.49) CYP19A1SMN1; SMN2ALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198199-A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2002-12-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198199-A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade TFPI, F2, PLAT CCR2 2642/4885CYP2C9 181/4885CYP3A4 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.